Filing Details

Accession Number:
0001140361-12-034904
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-08-02 20:13:02
Reporting Period:
2012-08-01
Filing Date:
2012-08-02
Accepted Time:
2012-08-02 19:13:02
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1048477 Biomarin Pharmaceutical Inc BMRN Pharmaceutical Preparations (2834) 680397820
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1197355 J Henry Fuchs C/O Biomarin Pharmaceutical Inc.
105 Digital Drive
Novato CA 94949
Evp, Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-08-01 5,000 $11.05 57,277 No 4 M Direct
Common Stock Disposition 2012-08-01 5,000 $38.63 52,277 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2012-08-01 5,000 $0.00 5,000 $11.05
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
311,000 2009-09-02 2019-03-01 No 4 M Direct
Footnotes
  1. Transaction made pursuant to a Rule 10b5-1 Trading plan executed on March 14, 2012.
  2. The range of sales prices received was $38.21 to $39.35. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information will be provided regarding the number of shares purchased or sold at each separate price.
  3. Original option grant vests 6/48ths on September 2, 2009 and 1/48th on the 2nd of each month thereafter.